ALI HEALTH (Alibaba Health Information Technology Limited) released an update on its corporate governance structure, confirming board and committee appointments that take effect on 29 July 2026.

The reconstituted Board will comprise six members: • Executive Directors: Mr. Shen Difan (Chairman and Chief Executive Officer) and Ms. Sheng Mengyue • Non-executive Director: Ms. Huang Jiaojiao • Independent Non-executive Directors: Ms. Huang Yi Fei (Vanessa), Dr. Shao Rong and Ms. Wu May Yihong

Committee composition is as follows:

Audit Committee • Chair: Ms. Wu May Yihong • Members: Ms. Huang Jiaojiao, Ms. Huang Yi Fei (Vanessa), Dr. Shao Rong

Nomination Committee • Chair: Mr. Shen Difan • Members: Dr. Shao Rong, Ms. Wu May Yihong

Remuneration Committee • Chair: Ms. Huang Yi Fei (Vanessa) • Member: Ms. Wu May Yihong

The announcement confirms that all appointments are effective immediately from the stated date, strengthening oversight across audit, nomination and remuneration matters. No additional governance or operational changes were disclosed in the document.